Literature DB >> 17521858

[Paclitaxel-induced lupus].

Alain Lortholary1, Myriam Cary-Ten Have Dallinga, Claude El Kouri, Nadine Morineau, Jean-François Ramée.   

Abstract

INTRODUCTION: Paclitaxel (Taxol) is a drug derived from the bark of the Pacific yew tree and is widely used in cancer treatment, especially for breast, ovarian, and lung cancers. It has not previously been reported to induce lupus. CASE: We report the case of a woman with ovarian cancer who developed paclitaxel-induced lupus on two occasions. Both times, the paclitaxel dramatically improved the ovarian cancer. DISCUSSION: The diagnosis of lupus was confirmed by the initial skin appearance, elevated levels of antinuclear antibodies, recurrence on reintroduction, and biopsy results. To our knowledge, it is the first case reported of paclitaxel-induced lupus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521858     DOI: 10.1016/j.lpm.2007.02.032

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Cremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature.

Authors:  Anthony Q Pham; David Berz; Patricia Karwan; Gerald A Colvin
Journal:  Case Rep Oncol       Date:  2011-10-26

2.  Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case report.

Authors:  Noelle Y Wong; Laurie M Parsons; Martin J Trotter; Roger Y Tsang
Journal:  BMC Res Notes       Date:  2014-11-05

Review 3.  Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review.

Authors:  George Zarkavelis; Aristomenes Kollas; Eleftherios Kampletsas; Vasilis Vasiliou; Evripides Kaltsonoudis; Alexandros Drosos; Hussein Khaled; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2016-04-23       Impact factor: 10.479

4.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.